286 related articles for article (PubMed ID: 12520583)
1. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
Tanaka M; Kitajima Y; Sato S; Miyazaki K
Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
[TBL] [Abstract][Full Text] [Related]
3. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin.
Kigure S
Rinsho Byori; 2006 May; 54(5):447-52. PubMed ID: 16789413
[TBL] [Abstract][Full Text] [Related]
6. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma.
Ando H; Aihara R; Ohno T; Ogata K; Mochiki E; Kuwano H
Br J Surg; 2009 Aug; 96(8):901-9. PubMed ID: 19591170
[TBL] [Abstract][Full Text] [Related]
8. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of gastric mucin in normal and disease states.
Taylor KL; Mall AS; Barnard RA; Ho SB; Cruse JP
Oncol Res; 1998; 10(9):465-73. PubMed ID: 10223622
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
11. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
12. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
[TBL] [Abstract][Full Text] [Related]
13. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
16. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
17. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
18. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
[TBL] [Abstract][Full Text] [Related]
19. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype.
Motoshita J; Nakayama H; Taniyama K; Matsusaki K; Yasui W
Pathol Int; 2006 Apr; 56(4):200-5. PubMed ID: 16634965
[TBL] [Abstract][Full Text] [Related]
20. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]